VLDL-triglyceride Under Acute Hyperinsulinaemia

Obesity Clinical Trial

Official title:

VLDL-triglyceride Under Acute Hyperinsulinaemia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00624104
• Other study ID #: ES-0001
• Status: Completed
• Phase: N/A
• First received: February 18, 2008
• Last updated: November 4, 2011
• Start date: March 2008
• Est. completion date: December 2010

Study information

• Verified date: November 2011
• Source: University of Aarhus
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Danish Dataprotection Agency
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to investigate and compare the lipid metabolism in lean and obese individuals. We want to investigate the effect of postprandial hyperinsulinaemia on VLDL-triglyceride metabolism

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. completion date: December 2010
• Est. primary completion date: December 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• Written consent

Exclusion Criteria:

• Known diseases

• Alcohol abuse

• Smoker

• Regular use of medicine

Study Design

N/A

Related Conditions & MeSH terms

• Hyperinsulinism
• Obesity

Intervention

Dietary Supplement:
• Food (fat free meal)
Fat free meal (40% of REE)

Locations

Country	Name	City	State
Denmark	Department of Endocrinology M, Aarhus Hospital	Aarhus C

Sponsors (1)

Lead Sponsor	Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VLDL metabolism		Few hours	No